Impact of prior androgen receptor-axis-targeted agents on the clinical activity of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer: comparative assessment between abiraterone acetate and enzalutamide.
about
Impact of prior androgen receptor-axis-targeted agents on the clinical activity of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer: comparative assessment between abiraterone acetate and enzalutamide.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Impact of prior androgen recep ...... rone acetate and enzalutamide.
@en
Impact of prior androgen recep ...... rone acetate and enzalutamide.
@nl
type
label
Impact of prior androgen recep ...... rone acetate and enzalutamide.
@en
Impact of prior androgen recep ...... rone acetate and enzalutamide.
@nl
prefLabel
Impact of prior androgen recep ...... rone acetate and enzalutamide.
@en
Impact of prior androgen recep ...... rone acetate and enzalutamide.
@nl
P2093
P2860
P1433
P1476
Impact of prior androgen recep ...... erone acetate and enzalutamide
@en
P2093
Atsushi Otsuka
Daisuke Motoyama
Keita Tamura
Takayuki Sugiyama
Toshiki Ito
Yuto Matsushita
P2860
P2888
P356
10.1007/S12032-017-1060-9
P577
2017-11-21T00:00:00Z